Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, controlled, parallel-group, multicenter, Phase-3 study to
evaluate the efficacy and safety of ezetimibe with simvastatin taken alone in subjects ages
10-17 years with Heterozygous Familial Hypercholesterolemia.